Skip to content

Medical-device intelligence

Apex BioTechnology Corp.: FDA clearances and recalls

Research Apex BioTechnology Corp. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

35 clearance records and 0 recall records in the covered releases, across 1 source company names and 5 product codes. Dated history runs from Jan 22, 2001 to Apr 4, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

35 matching records
Device / recordCompany in FDA recordSourceSource date
UASure II Blood Uric Acid Monitoring SystemK242209 · PTCApex BioTechnology Corp.510(k)Apr 4, 2025FDA decision date
GlucoSure ADVANCE Link Blood Glucose Monitoring SystemK222234 · NBWApex BioTechnology Corp.510(k)Dec 21, 2022FDA decision date
BGM039 Blood Glucose Monitoring System, BGM039 Link Blood Glucose Monitoring SystemK220421 · NBWApex BioTechnology Corp.510(k)Nov 4, 2022FDA decision date
GlucoSure Link Blood Glucose Monitoring SystemK212140 · NBWApex BioTechnology Corp.510(k)Aug 25, 2022FDA decision date
MTM301 Blood Glucose and Ketone Monitoring SystemK202534 · NBWApex BioTechnology Corp.510(k)Apr 6, 2022FDA decision date
GAL-1A Plus Blood Glucose Monitoring SystemK213887 · NBWApex BioTechnology Corp.510(k)Mar 29, 2022FDA decision date
MultiSure GK Link Blood Glucose and Ketone Monitoring SystemK201880 · NBWApex BioTechnology Corp.510(k)Oct 15, 2021FDA decision date
GlucoSure HT Plus Blood Glucose Monitoring SystemK202885 · NBWApex BioTechnology Corp.510(k)Sep 15, 2021FDA decision date
KET-1 Blood Ketone Monitoring SystemK182593 · JINApex BioTechnology Corp.510(k)Dec 18, 2018FDA decision date
BGM014 Blood Glucose Monitoring SystemK182992 · NBWApex BioTechnology Corp.510(k)Nov 28, 2018FDA decision date
BGM009 Plus Blood Glucose Monitoring SystemK170267 · NBWApex BioTechnology Corp.510(k)Mar 9, 2017FDA decision date
BGM014 Blood Glucose Monitoring System, BGM014 Pro Blood Glucose Monitoring SystemK161299 · NBWApex BioTechnology Corp.510(k)Dec 23, 2016FDA decision date
Autosure Voice II Blood Glucose Monitoring System, Autosure Voice II Pro Blood Glucose Monitoring System, Autosure Blood Glucose Test Strips, Aut…K150396 · NBWApex BioTechnology Corp.510(k)Oct 14, 2015FDA decision date
GAL-1F Blood Glucose Monitoring System, GAL-1F Pro Blood Glucose Monitoring SystemK142689 · CGAApex BioTechnology Corp.510(k)Aug 6, 2015FDA decision date
MEG-2B Blood Glucose Monitoring System, MEG-2B Pro Blood Glucose Monitoring SystemK143750 · CGAApex BioTechnology Corp.510(k)May 7, 2015FDA decision date
BGM009 BLOOD GLUCOSE MONITORING SYSTEMK141036 · NBWApex BioTechnology Corp.510(k)May 1, 2015FDA decision date
AUTOSURE HT BLOOD GLUCOSE MONITORING SYSTEMK131750 · CGAApex BioTechnology Corp.510(k)Mar 6, 2014FDA decision date
AUTOSURE VOICE 3 PLUS BLOOD GLUCOSE MONITORING SYSTEMK120649 · NBWApex BioTechnology Corp.510(k)Jul 6, 2012FDA decision date
MEG-2B BLOOD GLUCOSE MONITORING SYSTEM, PRO BLOOD GLUCOSE MONITORING SYSTEM, BLOOD GLUCOSE TEST STRIPS, GLUCOSE CONTROLK120448 · CGAApex BioTechnology Corp.510(k)Apr 6, 2012FDA decision date
GAL-1E BLOOD GLUCOSE MONITORING SYSTEM GAL-1E BLOOD GLUCOSE TEST STRIPS GAL-1E MULTI BLOOD GLUCOSE MONITORING SYSTEM GALK113547 · CGAApex BioTechnology Corp.510(k)Mar 28, 2012FDA decision date
GAL-1A BLOOD GLUCOSE MONITORING SYSTEMK113208 · CGAApex BioTechnology Corp.510(k)Jan 26, 2012FDA decision date
AUTOSURE VOICE II PLUS, AUTOSURE PLUS BLOOD GLUCOSE TEST STRIPS,CONTREX PLUS IIIK113098 · NBWApex BioTechnology Corp.510(k)Jan 17, 2012FDA decision date
GAL-1C BLOOD GLUCOSE MONITORING SYSTEM, GAL-1C TEST STRIPSK102816 · NBWApex BioTechnology Corp.510(k)Sep 15, 2011FDA decision date
MEG-2 BLOOD GLUCOSE MONITORING SYSTEM, MEG-2 50'S TEST STRIP, MEG-2 CONTROL SOLUTIONK101204 · CGAApex BioTechnology Corp.510(k)Aug 31, 2011FDA decision date
AUTOSURE VOICE 3 BLOOD GLUCOSE MONITORING SYSTEM AND TEST STRIPK102481 · NBWApex BioTechnology Corp.510(k)Apr 28, 2011FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗